Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/TCE2 stock hub

FRA/TCE2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/TCE2is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/TCE2
In the news

Latest news · FRA/TCE2

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-48.9
P25 n/aP50 n/aP75 n/a
ROIC-33.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/TCE2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
161
Groups with data
11
Currency
USD
Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
198
Employees Change
26%
Employees Change Percent
16.25
Enterprise value
EUR 1.9B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 2.3B
Price
EUR 28.74
Price currency
EUR
Rev Per Employee
3,788.96x
Sic
2836
Symbol
fra/TCE2
Website
https://www.celldex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-10.86%
EV Earnings
-7.66x
EV/FCF
-9.6x
FCF yield
-8.66%
P/B ratio
5.73x
P/S ratio
3,019.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Gross Profit
EUR -211.8M
Net Income
EUR -246M
Pretax Margin
-32,791.42%
Profit Per Employee
EUR -1.2M
ROA
-30.89
Roa5y
-19.34
ROCE
-67.22
ROE
-48.94
Roe5y
-31.49
ROIC
-33.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr10y
-4.34%
Cagr15y
-2.38%
Cagr1y
79.7%
Cagr3y
0.63%
Cagr5y
5.68%
Revenue Growth
-88.56x
Revenue Growth Q
-97.84x
Revenue Growth3 Y
-35x
Revenue Growth5 Y
-30.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 0
Assets
EUR 443.4M
Cash
EUR 391.5M
Current Assets
EUR 389.4M
Current Liabilities
EUR 43.6M
Debt
EUR 1.7M
Debt Equity
EUR 0
Debt FCF
EUR -0.01
Equity
EUR 395.7M
Liabilities
EUR 47.7M
Long Term Assets
EUR 54M
Long Term Liabilities
EUR 4.1M
Net Cash
EUR 389.9M
Net Cash By Market Cap
EUR 17.21
Net Cash Growth
-32.89%
Net Debt Equity
EUR -0.99
Tangible Book Value
EUR 372.1M
Tangible Book Value Per Share
EUR 5.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
8.92
Net Working Capital
EUR -36.6M
Quick ratio
8.78
Working Capital
EUR 353.6M
Working Capital Turnover
EUR 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-35.83%
1Y total return
79.63%
200-day SMA
22.61
3Y total return
1.92%
50-day SMA
26.83
50-day SMA vs 200-day SMA
50over200
5Y total return
31.84%
All Time High
460
All Time High Change
-93.75%
All Time High Date
2015-03-19
All Time Low
1.41
All Time Low Change
1,938.3%
All Time Low Date
2020-03-17
ATR
0.59
Ch YTD
30.64
High
28.74
High52
29.22
High52 Date
2026-04-20
High52ch
-1.64%
Low
27.98
Low52
16.5
Low52 Date
2025-05-12
Low52ch
74.18%
Ma50ch
7.13%
Price vs 200-day SMA
27.13%
RSI
58.24
RSI Monthly
56.25
RSI Weekly
65.98
Sharpe ratio
1.11x
Sortino ratio
2.01
Total Return
-0.29%
Tr YTD
30.64
Tr15y
-30.38%
Tr1m
6.84%
Tr1w
5.9%
Tr3m
52.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -268.1M
Operating margin
-35,729.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
72,360,818%
Shares Insiders
0.24%
Shares Institutions
86.24%
Shares Qo Q
0.12%
Shares Yo Y
0.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
EUR -226.9M
Average Volume
5.9x
Bv Per Share
5.94
CAPEX
EUR -3.5M
Ch10y
-35.83
Ch15y
-30.38
Ch1m
6.84
Ch1w
5.9
Ch1y
79.63
Ch3m
52.06
Ch3y
1.92
Ch5y
31.84
Ch6m
44.42
Change
-0.17%
Change From Open
2.72
Close
28.79
Days Gap
-2.81
Depreciation Amortization
2,855,088.1
Dollar Volume
3,305.1
Earnings Date
2026-05-11
EBIT
EUR -268.1M
EBITDA
EUR -265.1M
EPS
EUR -3.7
F Score
1
FCF
EUR -196.2M
FCF EV Yield
-10.42x
Financing CF
2,179,525
Fiscal Year End
December
Investing CF
206,626,419
Is Primary Listing
0
Last Earnings Date
2026-02-23
Last Report Date
2026-03-31
Last Split Date
2019-02-11
Last Split Type
Reverse
Ma150
23.56
Ma150ch
21.98%
Ma20
28.18
Ma20ch
2%
Net CF
16,125,709
Next Earnings Date
2026-05-11
Open
27.98
Position In Range
100
Ppne
7,977,626.5
Price Date
2026-05-08
Ptbv Ratio
6.09
Relative Volume
19.49x
Revenue
750,215x
SBC By Revenue
4,095.26x
Share Based Comp
30,723,235
Tr6m
44.42%
Volume
115
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/TCE2 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/TCE2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+79.6%
S&P 500 1Y: n/a
3Y total return
+1.9%
S&P 500 3Y: n/a
5Y total return
+31.8%
S&P 500 5Y: n/a
10Y total return
-35.8%
S&P 500 10Y: n/a
Ownership

Who owns FRA/TCE2?

Insider, institutional, and short-interest positioning.

Institutional ownership
+86.2%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.3%
Negative means the company is buying back shares.
Technical

FRA/TCE2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
58.2
Neutral momentum band
Price vs 200-day MA
+27.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.11
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/TCE2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/TCE2 stock rating?

fra/TCE2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/TCE2 analysis?

The full report lives at /stocks/fra/TCE2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/TCE2?

The latest report frames fra/TCE2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/TCE2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/TCE2 stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام